Abstract: Disclosed is a computing apparatus implemented with a network hypervisor implementing software defined network (SDN)-based network virtualization. The computing apparatus include a statistics virtualization module configured to provide individual statistics to each of created virtual networks, a transmission disaggregation module configured to include a physical statistics cache that performs periodic monitoring of a plurality of physical switches and store statistics of the physical switches collected, and a physical statistics aggregation module configured to respond with statistics of the plurality of physical switches when a single monitoring request.
Type:
Grant
Filed:
December 21, 2020
Date of Patent:
January 24, 2023
Assignee:
Korea University Research and Business Foundation
Abstract: The present invention relates, inter alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a catecholamine at a dose equivalent to at least about 0.2 mcg/kg/min of norepinephrine a dose of angiotensin II which is effective to raise the blood pressure of the subject to a mean arterial pressure (MAP) of about 65 mm Hg or above, and which is effective to reduce the dose of the catecholamine required to maintain a MAP of about 65 mm Hg to the equivalent of about 0.05-0.2 mcg/kg/min norepinephrine or less, or to the equivalent of about 0.05 mcg/kg/min norepinephrine or less.
Type:
Grant
Filed:
July 20, 2021
Date of Patent:
January 24, 2023
Assignee:
The George Washington University, A Congressionally Chartered Not-For-Profit Corporation
Abstract: Described herein are devices incorporating Casimir cavities, which modify the quantum vacuum mode distribution within the cavities. The Casimir cavities can drive charge carriers from or to an electronic device disposed adjacent to or contiguous with the Casimir cavity by modifying the quantum vacuum mode distribution incident on one side of the electronic device to be different from the quantum vacuum mode distribution incident on the other side of the electronic device. The electronic device can exhibit a structure that permits transport or capture of hot carriers in very short time intervals, such as in 1 picosecond or less.
Type:
Grant
Filed:
September 15, 2021
Date of Patent:
January 24, 2023
Assignee:
The Regents of the University of Colorado, a Body Corporate
Abstract: A system for providing an actuated-wall visual effect in an amusement park environment, the system comprising a panel mounting frame and a panel coupled to the panel mounting frame via a damper. The system also comprises a transducer mounting frame and a transducer configured to convert an audio signal into mechanical energy. The transducer comprises a first portion coupled to the transducer frame and a second portion coupled to the panel such that the transducer is configured to oscillate the panel relative to the transducer mounting frame in response to receiving the audio signal.
Type:
Grant
Filed:
June 24, 2021
Date of Patent:
January 24, 2023
Assignee:
Universal City Studios LLC
Inventors:
Andrew Christopher Koers, Gary Andrew Brown, Phillip Ben Burgos
Abstract: An electrocardiography device is described that can include a main body, an adjustable cap, and a power switch. The main body can include an electrode of a plurality of electrodes configured to acquire electrical signal from a patient. The adjustable cap can include two electrodes of the plurality of electrodes. The adjustable cap can be rotatable around an axis on the main body to orient the plurality of electrodes on different locations on a body of the patient. The power switch can activate the plurality of electrodes to acquire the electrical signal from the patient. Related apparatuses, systems, methods, techniques and articles are also described.
Type:
Grant
Filed:
December 6, 2018
Date of Patent:
January 24, 2023
Assignee:
The Aga Khan University
Inventors:
Saleem Sayani, Muhammad Abdul Muqeet, Hafiz Imtiaz Ahmed, Hafsa Talat, Ayeesha Kamran Kamal, Ambreen Amir Ali, Naeem Sheikh
Abstract: Disclosed herein are compounds which inhibit the kinase activity of dual leucine zipper (DLK) kinase (MAP3K12), pharmaceutical compositions, and methods of treatment of DLK-mediated diseases, such as neurological diseases that result from traumatic injury to central nervous system and peripheral nervous system neurons (e.g. stroke, traumatic brain injury, spinal cord injury), or that result from a chronic neurodegenerative condition (e.g. Alzheimer's disease, frontotemporal dementia, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinocerebellar ataxia, progressive supranuclear palsy, Lewy body disease, Kennedy's disease, and other related conditions), from neuropathies resulting from neurological damage (chemotherapy-induced peripheral neuropathy, diabetic neuropathy, and related conditions) and from cognitive disorders caused by pharmacological intervention (e.g. chemotherapy induced cognitive disorder, also known as chemobrain).
Type:
Grant
Filed:
October 20, 2020
Date of Patent:
January 24, 2023
Assignee:
Board of Regents, The University of Texas System
Inventors:
Michael J. Soth, Kang Le, Philip Jones, Jason Cross
Abstract: An amusement park system includes a modular attraction system having a ride vehicle having seats to accommodate passengers, an on-board system integrated with the ride vehicle and having on-board game systems connected via a network. Each on-board game system is configured to provide an augmented reality (AR) experience, or a virtual reality (VR) experience, or both, via a respective visual experience generator device. The AR experience, or the VR experience, or both, is provided within a game shared between the on-board game systems. The on-board game systems are integrated into the ride vehicle, and are connected via the network to one another in a manner that allows for ready removal of all or a portion of one of the on-board game systems without affecting operation of the remaining on-board game systems.
Type:
Grant
Filed:
September 24, 2019
Date of Patent:
January 24, 2023
Assignee:
Universal City Studios LLC
Inventors:
Patrick John Goergen, Danielle Marie Holstine, Tomas Manuel Trujillo
Abstract: A system for generating X-ray beams from a liquid target includes a vacuum chamber, a diamond window assembly, an electron source, a target material flow system, and an X-ray detector/imager. An electron beam from the electron source travels through the diamond window assembly and into a dynamic target material of the flow system. Preferably, the dynamic target material is lead bismuth eutectic in a liquid state. Upon colliding with the dynamic target material, X-rays are generated. The generated X-rays exit through an X-ray exit window to be captured by the X-ray detector/imager. Since the dynamic target material is constantly in fluid motion within a pipeline of the flow system, the electron beam always has a new target area which is at a controlled operational temperature and thus, prevents overheating issues. By providing a small focus area for the electron beams, the overall imaging resolution of the X-rays is also improved.
Type:
Grant
Filed:
August 18, 2021
Date of Patent:
January 24, 2023
Assignee:
King Fahd University of Petroleum and Minerals
Abstract: In one representative embodiment, a method of perfusing organs in a patient's body is provided. The method comprises isolating the visceral arteries and the visceral veins from blood circulating through the patient's heart and perfusing the visceral arteries, the visceral veins, and the abdominal organs with a perfusion fluid that is fluidly separated from the blood circulating through the patient's heart. While the visceral arteries and the visceral veins are isolated, and the visceral arteries, the visceral veins, and the abdominal organs are being perfused, the patient's blood is allowed to continue to circulate through the heart.
Type:
Grant
Filed:
April 29, 2019
Date of Patent:
January 24, 2023
Assignee:
University of Pittsburgh—Of the Commonwealth System of Higher Education
Inventors:
Bryan W. Tillman, Amit D. Tevar, Youngjae Chun
Abstract: The present invention provides a new antibody against ECSA type Chikungunya virus, WA type Chikungunya virus, and Asian type Chikungunya virus or an antigen-binding fragment of the antibody. The antibody against Chikungunya virus or the antigen-binding fragment of the antibody of the present invention includes a heavy chain variable region or a heavy chain (1), (2), or (3) and a light chain variable region or a light chain (4).
Abstract: Disclosed is a method for expecting and diagnosing UQCRB-related disease, and more particularly, related to a method for diagnosing a UQCRB-related disease and a cholesterol biosynthesis related disease, as well as expecting risks of post-occurrence of the UQCRB-related disease and the cholesterol biosynthesis related disease, simply by measuring an expression level of miRNA, and a kit and a biomarker composition for the method.
Type:
Grant
Filed:
February 7, 2020
Date of Patent:
January 24, 2023
Assignee:
Industry-Academic Cooperation Foundation, Yonsei University
Abstract: Chalcogenide waveguides with high width-to-height aspect ratios and a smooth exposed surfaces can serve as mid-infrared evanescent-absorption-based sensors for detecting and identifying volatile organic compounds and/or determining their concentration, optionally in real-time. The waveguide sensors may be manufactured using a modified sputtering process in which the sputtering target and waveguide substrate are titled and/or laterally offset relative to each other and the substrate is continuously rotated.
Abstract: The presently disclosed subject matter provides synergistic mixtures for inducing hygienic behavior in honey bees and related compositions and methods.
Type:
Grant
Filed:
October 11, 2021
Date of Patent:
January 24, 2023
Assignee:
University of North Carolina at Greensboro
Abstract: This disclosure relates to genetically engineered microorganisms for treating or reducing the risk of bacterial infections or dysbiosis, and further discloses methods of making and using such microorganisms.
Type:
Grant
Filed:
September 14, 2018
Date of Patent:
January 24, 2023
Assignee:
University of Massachusetts
Inventors:
Vanni Bucci, Jacob Palmer, Christopher Brigham, Mark Silby
Abstract: Various implementations include a Human Thermoregulation Simulator (HTRS) that simulates the natural and primary thermoregulatory functions of a patient that are relevant during therapeutic hypothermia procedures. For example, in various implementations, a HTRS includes a core container configured to be at least partially filled with water, and the core container includes a heat generator configured to heat the water inside the core container. A middle container is disposed concentrically around the core container, and the middle container includes a foam layer configured to be saturated by water. An outer container is disposed concentrically around the middle container, and the outer container includes a network of tubing disposed on at least a portion of an inner surface of the outer container. The HTRS also includes a pump configured to circulate water from the core container through the network of tubing.
Type:
Grant
Filed:
August 30, 2018
Date of Patent:
January 24, 2023
Assignee:
Board of Regents, The University of Texas System
Inventors:
Kenneth R. Diller, Priya Chacko, Ali Seifi
Abstract: An integrated flexible thermoelectric device includes p-type carbon nanoparticle regions and n-type carbon nanoparticle regions which are alternately and continuously connected to each other. In particular, the p-type carbon nanoparticle regions and the n-type carbon nanoparticle regions are formed on the one carbon nanoparticle paper.
Type:
Grant
Filed:
March 1, 2021
Date of Patent:
January 24, 2023
Assignees:
Hyundai Motor Company, Kia Motors Corporation, Kookmin University Industry Academy Cooperation Foundation
Inventors:
Eun Yeong Lee, Mi Yeon Song, Sang Hak Kim, Hyun Jung Lee, Hyun Woo Bark, Young Hoe Kim
Abstract: A high spatial and temporal resolution synthetic aperture phase microscopy (HISTR-SAPM) system and methods are provided for sample imaging and metrology. The HISTR-SAPM system includes a sample-illumination path along which a first illumination beam propagates and a reference-beam path along which a second illumination beam propagates. A first digital micromirror device (DMD), a second DMD, and a first scanning objective lens are disposed in the sample-illumination path and at a first side adjacent to the sample. A second scanning objective lens passes the sample information to a beam splitter (BS), where the sample illumination beam and the reference-beam are combined to form an interferogram at a final image plane for imaging the sample. A Fourier spatial spectrum analysis and a synthetic aperture are then used to reconstruct a quantitative phase map of the sample with a high resolution and at a high-speed.
Abstract: A method of encapsulating a solid sample in a droplet, the method including flowing a continuous phase through a first fluid channel at a first flow rate; flowing a dispersed phase through a second fluid channel at a second flow rate, the dispersed phase including a plurality of particles, cells or beads; trapping the plurality of particles, cells or beads in a mixing region that receives the dispersed phase and the continuous phase; and reducing the first flow rate to encapsulate the trapped particles, cells or beads in droplets of the dispersed phase generated when the dispersed phase and the continuous phase exit the mixing region through an orifice.
Type:
Grant
Filed:
September 16, 2019
Date of Patent:
January 24, 2023
Assignee:
The Regents of the University of California
Inventors:
Abraham P. Lee, Roger Shih, Wei-Feng Fang, Naiqing Zhang
Abstract: Disclosed are compositions comprising myokines and their methods of preparation and use. The disclosed myokine compositions and methods may comprise myokines having a molecular weight of greater than about 10 kDa such as myostatin and metrnl. The disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders. In particular, the disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders, such as cancer, and metabolic diseases and disorders, such as diabetes, non-alcoholic fatty liver disease, and heart disease.
Abstract: A pecan tree distinguished by the following unique combination of characteristics: large nut size, bright kernel color, good shelling ability, moderately early harvest date, and good resistance to the scab fungus (Venturia effuse) in sprayed orchards.
Type:
Grant
Filed:
March 4, 2022
Date of Patent:
January 24, 2023
Assignee:
University of Georgia Research Foundation, Inc.